Tower Research Capital LLC (TRC) - CUREVAC N V ownership

CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 1 filers reported holding CUREVAC N V in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CUREVAC N V
ValueSharesWeighting
Q3 2023$38,180
-59.0%
5,590
-37.4%
0.00%
-66.7%
Q2 2023$93,113
+846381.8%
8,936
+482.5%
0.00%
Q1 2023$11
-70.3%
1,534
-75.3%
0.00%
-100.0%
Q4 2022$37
-99.7%
6,208
+283.4%
0.00%
Q3 2022$13,000
-75.0%
1,619
-57.7%
0.00%
-100.0%
Q2 2022$52,000
+147.6%
3,830
+243.2%
0.00%
Q1 2022$21,000
-82.6%
1,116
-68.4%
0.00%
-100.0%
Q4 2021$121,000
+706.7%
3,531
+1170.1%
0.00%
Q3 2021$15,000
-97.4%
278
-96.4%
0.00%
-100.0%
Q2 2021$567,0007,7260.02%
Other shareholders
CUREVAC N V shareholders Q4 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 3,134,780$230,000,00035.34%
Affinity Asset Advisors, LLC 150,000$11,022,0003.95%
SHANDA ASSET MANAGEMENT HOLDINGS Ltd 132,300$9,722,0000.79%
Renaissance Capital LLC 56,915$4,182,0000.66%
QCM Cayman, Ltd. 2,744$202,0000.52%
Green Alpha Advisors, LLC 4,545$334,0000.23%
Baillie Gifford 5,515,262$405,261,0000.20%
CSS LLC/IL 60,000$4,408,0000.18%
Caption Management, LLC 161,400$11,860,0000.16%
MANGROVE PARTNERS IM, LLC 20,200$1,484,0000.15%
View complete list of CUREVAC N V shareholders